Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1977 1
1978 1
1979 2
1980 2
1981 4
1982 8
1983 6
1984 3
1985 13
1986 8
1987 14
1988 17
1989 6
1990 26
1991 19
1992 32
1993 29
1994 25
1995 45
1996 38
1997 40
1998 30
1999 37
2000 40
2001 49
2002 40
2003 52
2004 74
2005 85
2006 118
2007 154
2008 148
2009 142
2010 211
2011 219
2012 223
2013 263
2014 279
2015 230
2016 206
2017 161
2018 124
2019 113
2020 140
2021 130
2022 119
2023 97
2024 114
2025 105
2026 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,514 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Macrogol (polyethylene glycol) laxatives in children with functional constipation and faecal impaction: a systematic review.
Candy D, Belsey J. Candy D, et al. Arch Dis Child. 2009 Feb;94(2):156-60. doi: 10.1136/adc.2007.128769. Epub 2008 Nov 19. Arch Dis Child. 2009. PMID: 19019885 Free PMC article.
A comprehensive literature search was carried out to identify randomised controlled trials of polyethylene glycol (PEG) versus either placebo or active comparator, in patients aged <18 years with primary chronic constipation. ...
A comprehensive literature search was carried out to identify randomised controlled trials of polyethylene glycol (PEG) versus either …
Multizentrische, randomisierte, offene Parallelarm-Umbrella-Studie JAVELIN Bladder Medley der Phase II zu Avelumab (MSB0010718C) in Kombination mit Sacituzumab Govitecan, M6223 und NKTR-255 als Erhaltungstherapie bei Teilnehmern mit lokal fortgeschrittenem oder metastasiertem Urothelkarzinom, deren Erkrankung unter einer platinhaltigen Erstlinien(1L)-Chemotherapie nicht fortgeschritten ist. – JAVELIN Bladder Medley – AB 88/23 der AUO.
[No authors listed] [No authors listed] Aktuelle Urol. 2023 Dec;54(6):438-440. doi: 10.1055/a-2059-0738. Epub 2023 Nov 16. Aktuelle Urol. 2023. PMID: 37972619 Clinical Trial. German. No abstract available.
Effect of Acupuncture in Patients With Irritable Bowel Syndrome: A Randomized Controlled Trial.
Pei L, Geng H, Guo J, Yang G, Wang L, Shen R, Xia S, Ding M, Feng H, Lu J, Li J, Liu L, Shu Y, Fang X, Wu X, Wang X, Weng S, Ju L, Chen X, Shen H, Sun J. Pei L, et al. Mayo Clin Proc. 2020 Aug;95(8):1671-1683. doi: 10.1016/j.mayocp.2020.01.042. Epub 2020 Jun 1. Mayo Clin Proc. 2020. PMID: 32499125 Free article. Clinical Trial.
OBJECTIVE: To evaluate the effect and safety of acupuncture for the treatment of irritable bowel syndrome (IBS) through comparisons with those of polyethylene glycol (PEG) 4000 and pinaverium bromide. PATIENTS AND METHODS: This multicenter randomized controlled trial was c …
OBJECTIVE: To evaluate the effect and safety of acupuncture for the treatment of irritable bowel syndrome (IBS) through comparisons with tho …
Lactulose versus Polyethylene Glycol for Chronic Constipation.
Lee-Robichaud H, Thomas K, Morgan J, Nelson RL. Lee-Robichaud H, et al. Cochrane Database Syst Rev. 2010 Jul 7;(7):CD007570. doi: 10.1002/14651858.CD007570.pub2. Cochrane Database Syst Rev. 2010. PMID: 20614462
BACKGROUND: Constipation is a common clinical problem. Lactulose and Polyethylene Glycol (PEG) are both commonly used osmotic laxatives that have been shown to be effective and safe treatments for chronic constipation. ...OBJECTIVES: To identify and review all relevant dat …
BACKGROUND: Constipation is a common clinical problem. Lactulose and Polyethylene Glycol (PEG) are both commonly used osmotic laxativ …
Prolonged-Release Oxycodone/Naloxone Improves Anal Sphincter Relaxation Compared to Oxycodone Plus Macrogol 3350.
Poulsen JL, Brock C, Grønlund D, Liao D, Gregersen H, Krogh K, Drewes AM. Poulsen JL, et al. Dig Dis Sci. 2017 Nov;62(11):3156-3166. doi: 10.1007/s10620-017-4784-7. Epub 2017 Oct 6. Dig Dis Sci. 2017. PMID: 28986667 Clinical Trial.

RESULTS: Both PR oxycodone/naloxone and PR oxycodone plus macrogol treatment decreased sphincter relaxation compared to baseline (- 27.5%; P < 0.001 and - 14.7%; P = 0.01). ...PAC-SYM abdominal symptoms score was lower during PR naloxone compared to macrogol (0.2

…
RESULTS: Both PR oxycodone/naloxone and PR oxycodone plus macrogol treatment decreased sphincter relaxation compared to baseline (- 2 …
Surfactant for babies.
[No authors listed] [No authors listed] Lancet. 1992 Dec 5;340(8832):1387. Lancet. 1992. PMID: 1360097 Clinical Trial. No abstract available.
OSIRIS trial.
Morley C. Morley C. Lancet. 1993 Jan 16;341(8838):172-3; author reply 173-4. Lancet. 1993. PMID: 8093764 Clinical Trial. No abstract available.
Effect of dose splitting of a low-volume bowel preparation macrogol-based solution on CT colonography tagging quality.
Mistretta F, Damiani N, Campanella D, Mazzetti S, Gulino A, Cappello G, Regge D. Mistretta F, et al. Radiol Med. 2022 Aug;127(8):809-818. doi: 10.1007/s11547-022-01514-4. Epub 2022 Jun 17. Radiol Med. 2022. PMID: 35715681 Free PMC article. Clinical Trial.
PURPOSE: To compare examination quality and acceptability of three different low-volume bowel preparation regimens differing in scheduling of the oral administration of a Macrogol-based solution, in patients undergoing computed tomographic colonography (CTC). ...
PURPOSE: To compare examination quality and acceptability of three different low-volume bowel preparation regimens differing in scheduling o …
OSIRIS trial.
Tarnow-Mordi W. Tarnow-Mordi W. Lancet. 1993 Jan 16;341(8838):174. Lancet. 1993. PMID: 8093765 Clinical Trial. No abstract available.
Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study.
Zangaglia R, Martignoni E, Glorioso M, Ossola M, Riboldazzi G, Calandrella D, Brunetti G, Pacchetti C. Zangaglia R, et al. Mov Disord. 2007 Jul 15;22(9):1239-44. doi: 10.1002/mds.21243. Mov Disord. 2007. PMID: 17566120 Clinical Trial.
The objective of this study is to determine the efficacy and safety of an isosmotic macrogol solution for the treatment of constipation in PD patients, in a double-blind, placebo-controlled study. A total of 57 PD patients with constipation were randomly assigned to receiv …
The objective of this study is to determine the efficacy and safety of an isosmotic macrogol solution for the treatment of constipati …
3,514 results